Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 365

Similar articles for PubMed (Select 16611910)

1.
2.

Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model.

Bartlett NW, Buttigieg K, Kotenko SV, Smith GL.

J Gen Virol. 2005 Jun;86(Pt 6):1589-96.

4.

An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity.

Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR.

J Immunol. 2008 Feb 15;180(4):2474-85.

6.

A critical role for IL-15 in TLR-mediated innate antiviral immunity against genital HSV-2 infection.

Thatte A, DeWitte-Orr SJ, Lichty B, Mossman KL, Ashkar AA.

Immunol Cell Biol. 2011 Aug;89(6):663-9. doi: 10.1038/icb.2011.7. Epub 2011 Feb 22.

PMID:
21339766
7.

Evaluation of the immunomodulatory and antiviral effects of the cytokine combination IFN-α and IL-7 in the lymphocytic choriomeningitis virus and Friend retrovirus mouse infection models.

Audigé A, Hofer U, Dittmer U, van den Broek M, Speck RF.

Viral Immunol. 2011 Oct;24(5):375-85. doi: 10.1089/vim.2011.0006. Epub 2011 Sep 19.

PMID:
21929334
8.

Interferons lambda, new cytokines with antiviral activity.

Lopušná K, Režuchová I, Betáková T, Skovranová L, Tomašková J, Lukáčiková L, Kabát P.

Acta Virol. 2013;57(2):171-9. Review.

PMID:
23600875
9.

Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-kappaB than type I IFNs.

Iversen MB, Ank N, Melchjorsen J, Paludan SR.

J Virol. 2010 May;84(9):4579-86. doi: 10.1128/JVI.02591-09. Epub 2010 Feb 24.

11.

Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.

Kawamoto S, Oritani K, Asada H, Takahashi I, Ishikawa J, Yoshida H, Yamada M, Ishida N, Ujiie H, Masaie H, Tomiyama Y, Matsuzawa Y.

J Virol. 2003 Sep;77(17):9622-31.

12.

Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.

Zhang SY, Boisson-Dupuis S, Chapgier A, Yang K, Bustamante J, Puel A, Picard C, Abel L, Jouanguy E, Casanova JL.

Immunol Rev. 2008 Dec;226:29-40. doi: 10.1111/j.1600-065X.2008.00698.x. Review.

PMID:
19161414
13.

TRIM13 is a negative regulator of MDA5-mediated type I interferon production.

Narayan K, Waggoner L, Pham ST, Hendricks GL, Waggoner SN, Conlon J, Wang JP, Fitzgerald KA, Kang J.

J Virol. 2014 Sep;88(18):10748-57. doi: 10.1128/JVI.02593-13. Epub 2014 Jul 9.

14.

IFN-lambda: novel antiviral cytokines.

Ank N, West H, Paludan SR.

J Interferon Cytokine Res. 2006 Jun;26(6):373-9. Review.

PMID:
16734557
17.

Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma.

Lasfar A, Lewis-Antes A, Smirnov SV, Anantha S, Abushahba W, Tian B, Reuhl K, Dickensheets H, Sheikh F, Donnelly RP, Raveche E, Kotenko SV.

Cancer Res. 2006 Apr 15;66(8):4468-77.

20.

Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo.

Jewell NA, Cline T, Mertz SE, Smirnov SV, Flaño E, Schindler C, Grieves JL, Durbin RK, Kotenko SV, Durbin JE.

J Virol. 2010 Nov;84(21):11515-22. doi: 10.1128/JVI.01703-09. Epub 2010 Aug 25. Erratum in: J Virol. 2011 Jan;85(1):650.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk